Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Durvalumab With or Without Tremelimumab in Combination Wi... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study
0
Authors
Melissa Johnson
•
Sarayut Geater
16 more
•
Tony Mok
Published
November 3, 2022
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Clinical Oncology
Topics
Cancer Oncology
Internal Medicine
Gastroenterology
Medicine
Cancer Oncology
Internal Medicine
Gastroenterology
Cisplatin
Show all topics
DOI
10.1200/jco.22.00975
License
CC-BY-NC-ND
Other Formats
PDF
